Financials Elife Holdings Limited
Equities
223
KYG3002T1195
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.219 HKD | -0.45% | +0.46% | -48.47% |
Feb. 09 | Elife Raises HK$19.4 Million From Rights Issue | MT |
Feb. 07 | Elife Holdings Limited Announces Resignation of Lam Lee G. as Independent Non-Executive Director | CI |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 649 | 237 | 234.3 | 210.6 | 62.42 | 96.34 |
Enterprise Value (EV) 1 | 642.2 | 244.3 | 220.2 | 223.7 | 80.58 | 121.1 |
P/E ratio | -5 x | -1.3 x | -2.99 x | -7.56 x | -1.45 x | -4.3 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 4.24 x | 2.65 x | 4.28 x | 0.76 x | 0.41 x | 0.4 x |
EV / Revenue | 4.2 x | 2.73 x | 4.02 x | 0.81 x | 0.53 x | 0.51 x |
EV / EBITDA | -5.16 x | -1.71 x | -3.07 x | -7.35 x | -1.73 x | -5.11 x |
EV / FCF | -7.12 x | 45.7 x | 4.8 x | -25.2 x | -145 x | -19.6 x |
FCF Yield | -14% | 2.19% | 20.8% | -3.97% | -0.69% | -5.09% |
Price to Book | 2.27 x | 1.28 x | 1.9 x | 1.55 x | 0.53 x | 0.97 x |
Nbr of stocks (in thousands) | 519,216 | 557,554 | 593,194 | 619,329 | 678,529 | 752,689 |
Reference price 2 | 1.250 | 0.4250 | 0.3950 | 0.3400 | 0.0920 | 0.1280 |
Announcement Date | 7/16/18 | 7/23/19 | 7/17/20 | 7/27/21 | 7/18/22 | 7/27/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 153 | 89.37 | 54.79 | 276 | 152.6 | 238.8 |
EBITDA 1 | -124.3 | -143 | -71.7 | -30.44 | -46.55 | -23.67 |
EBIT 1 | -129.4 | -150.1 | -78.21 | -34.06 | -48.06 | -24.76 |
Operating Margin | -84.57% | -167.92% | -142.74% | -12.34% | -31.49% | -10.37% |
Earnings before Tax (EBT) 1 | -144.5 | -161.2 | -95.94 | -28.93 | -44.92 | -25.2 |
Net income 1 | -126.7 | -138.6 | -76.93 | -26.4 | -40.84 | -21.67 |
Net margin | -82.76% | -155.09% | -140.42% | -9.56% | -26.76% | -9.07% |
EPS 2 | -0.2500 | -0.3267 | -0.1322 | -0.0450 | -0.0637 | -0.0297 |
Free Cash Flow 1 | -90.17 | 5.342 | 45.88 | -8.877 | -0.554 | -6.163 |
FCF margin | -58.92% | 5.98% | 83.74% | -3.22% | -0.36% | -2.58% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 7/16/18 | 7/23/19 | 7/17/20 | 7/27/21 | 7/18/22 | 7/27/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 7.32 | - | 13.1 | 18.2 | 24.7 |
Net Cash position 1 | 6.84 | - | 14.2 | - | - | - |
Leverage (Debt/EBITDA) | - | -0.0512 x | - | -0.4306 x | -0.39 x | -1.044 x |
Free Cash Flow 1 | -90.2 | 5.34 | 45.9 | -8.88 | -0.55 | -6.16 |
ROE (net income / shareholders' equity) | -48.6% | -82.7% | -99.2% | -46.5% | -82% | -73.2% |
ROA (Net income/ Total Assets) | -24.7% | -35.2% | -27% | -16.5% | -26.7% | -17.2% |
Assets 1 | 513.5 | 393.6 | 285.1 | 160.2 | 152.9 | 125.7 |
Book Value Per Share 2 | 0.5500 | 0.3300 | 0.2100 | 0.2200 | 0.1700 | 0.1300 |
Cash Flow per Share 2 | 0.0200 | 0.0300 | 0.0300 | 0.0200 | 0.0200 | 0 |
Capex 1 | 20.1 | 0.89 | 0.06 | 0.11 | - | 0.04 |
Capex / Sales | 13.16% | 0.99% | 0.11% | 0.04% | - | 0.02% |
Announcement Date | 7/16/18 | 7/23/19 | 7/17/20 | 7/27/21 | 7/18/22 | 7/27/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-48.47% | 31.77M | |
-3.54% | 9.38B | |
+31.91% | 1.95B | |
-2.31% | 1.39B | |
-6.70% | 1.19B | |
-16.69% | 875M | |
+0.67% | 472M | |
+3.39% | 436M | |
-47.25% | 368M | |
-22.36% | 344M |
- Stock Market
- Equities
- 223 Stock
- Financials Elife Holdings Limited